1-11806126-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1
The ENST00000641747.1(MTHFR):n.-252G>A variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.0455 in 640,040 control chromosomes in the GnomAD database, including 792 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.037 ( 153 hom., cov: 33)
Exomes 𝑓: 0.048 ( 639 hom. )
Consequence
MTHFR
ENST00000641747.1 non_coding_transcript_exon
ENST00000641747.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.66
Publications
23 publications found
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
CLCN6 (HGNC:2024): (chloride voltage-gated channel 6) This gene encodes a member of the voltage-dependent chloride channel protein family. Members of this family can function as either chloride channels or antiporters. This protein is primarily localized to late endosomes and functions as a chloride/proton antiporter. Alternate splicing results in both coding and non-coding variants. Additional alternately spliced variants have been described but their full-length structure is unknown. [provided by RefSeq, Mar 2012]
CLCN6 Gene-Disease associations (from GenCC):
- neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalitiesInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.14).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0528 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0371 AC: 5643AN: 152200Hom.: 151 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
5643
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0481 AC: 23475AN: 487722Hom.: 639 Cov.: 7 AF XY: 0.0483 AC XY: 11711AN XY: 242544 show subpopulations
GnomAD4 exome
AF:
AC:
23475
AN:
487722
Hom.:
Cov.:
7
AF XY:
AC XY:
11711
AN XY:
242544
show subpopulations
African (AFR)
AF:
AC:
128
AN:
11146
American (AMR)
AF:
AC:
262
AN:
7736
Ashkenazi Jewish (ASJ)
AF:
AC:
541
AN:
10702
East Asian (EAS)
AF:
AC:
139
AN:
23838
South Asian (SAS)
AF:
AC:
538
AN:
14166
European-Finnish (FIN)
AF:
AC:
1125
AN:
34314
Middle Eastern (MID)
AF:
AC:
356
AN:
3094
European-Non Finnish (NFE)
AF:
AC:
19289
AN:
358646
Other (OTH)
AF:
AC:
1097
AN:
24080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1161
2321
3482
4642
5803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0371 AC: 5648AN: 152318Hom.: 153 Cov.: 33 AF XY: 0.0371 AC XY: 2762AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
5648
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
2762
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
454
AN:
41580
American (AMR)
AF:
AC:
618
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
188
AN:
3470
East Asian (EAS)
AF:
AC:
9
AN:
5182
South Asian (SAS)
AF:
AC:
203
AN:
4824
European-Finnish (FIN)
AF:
AC:
336
AN:
10622
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3689
AN:
68018
Other (OTH)
AF:
AC:
95
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
272
544
817
1089
1361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
109
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Homocystinuria due to methylene tetrahydrofolate reductase deficiency Benign:1
May 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.